Key result
Silent infective endocarditis post-CAR T-cell therapy can trigger septic coronary embolization and transient complete AV block.
Why the study?
This case report describes a rare, pathologically confirmed mechanism of conduction disturbance following CAR T-cell therapy.
Case Report (n=1)
No
Unexplained high-grade atrioventricular block in immunocompromised patients post-CAR T-cell therapy should prompt suspicion for silent infective endocarditis and septic coronary microembolism, even when inflammatory markers (CRP) and transthoracic echocardiography are normal.
Answers are grounded in this paper and cite their sources.
May prompt consideration of silent IE in post-CAR T AV block despite normal CRP; extends IE conduction mechanisms to include septic microembolism.
Silent infective endocarditis after CAR-T therapy caused septic embolic occlusion of a septal coronary branch, producing localized myocardial infarction involving the His bundle region and transient complete atrioventricular block. This case highlights a rare, pathologically confirmed mechanism of conduction disturbance.
No takes yet. Share an insight, caveat, or question.
Kito et al. (2026) conducted a case report in Transient third-degree atrioventricular block secondary to coronary artery embolism from infective endocarditis following CAR T-cell therapy for diffuse large B-cell lymphoma (n=1). CAR T-cell therapy complicated by silent infective endocarditis and septic coronary embolism was evaluated on Transient third-degree atrioventricular block and localized myocardial infarction involving the His bundle region. Silent infective endocarditis after CAR T-cell therapy caused septic embolic occlusion of a septal coronary branch, resulting in transient third-degree AV block (38 beats/min) and peak troponin T of 349.0 ng/L.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: